D-0710-2018 Class III Terminated

Recalled by Rhodes Pharmaceuticals, L.P. — Coventry, RI

FDA drug recall D-0710-2018 was initiated by Rhodes Pharmaceuticals, L.P. on Apr 17, 2018 and is designated Class III. Reason for recall: Failed Dissolution Specification: Low dissolution outside of specifications The recall status is terminated (terminated May 19, 2020). Affected quantity: 2454 bottles.

Recall details

Product Type
Drugs
Report Date
May 9, 2018
Initiation Date
Apr 17, 2018
Termination Date
May 19, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2454 bottles

Product description

Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45

Reason for recall

Failed Dissolution Specification: Low dissolution outside of specifications

Distribution pattern

Nationwide within the USA

Code information

Lot# AG8679B Exp. 01/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0710-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0710-2018. Report a data issue: hello@regdatalab.com.